Sweden· SE-20150808000086
Atosiban EVER Pharma 75 mg/10 ml Koncentrat till infusionsvätska, lösning
A atosiban product containing atosiban, registered in Sweden by EVER Valinject GmbH. The same ATC class is registered in 14 of our 19 countries.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
Where it is registered
Atosiban is registered in 14 of 19 countries.
Countries holding a registration under ATC G02CX01 (atosiban), each read from that country’s own register.
- This record: Sweden, from Swedish Medical Products Agency (Sweden)
- 8 of them publish a price we can compare per daily dose
Atosiban · ATC G02CX01
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Atosiban
- Manufacturer
- EVER Valinject GmbH
- Country
- Sweden (SE)
- ATC code
- G02CX01
- ATC class
- Atosiban
- Defined daily dose
- 165 mg, P
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20150808000086
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Atosiban in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAtosiban AccordAccord Healthcare B.V.
- PolandAtosiban AccordAccord Healthcare Polska Sp. z o.o.
- BelgiumAtosiban Ever Pharma 37.5 mg/5 mlEVER Valinject
- CzechiaATOSIBAN AVMCAV Medical CZ s.r.o., Praha
- NorwayAtosiban AccordAccord Healthcare B.V.
- SwitzerlandAtosiban Labatec 37.5 mg / 5 ml, solution à diluer pour perfusionLabatec Pharma SA
- IcelandAtosiban SUNSun Pharmaceutical Industries Europe B.V.*
- IrelandAtosiban SUN 37.5 mg/5 ml concentrate for solution for infusionSun Phamaceutical Industries Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Atosiban Altan, Atosiban Ever Pharma
- Belgium · Atosiban Ever Pharma
- Bulgaria · Атозибан Ever Pharma
- Czechia · Atosiban Avmc, Atosiban Ever Pharma
- Germany · Atosiban Ever Pharma, Atosiban Ibisqus
- Denmark · Atosiban Ever Pharma
- Spain · Atosiban Altan Pharmaceuticals, S.A., Atosiban Ever Pharma
- Finland · Atosiban Ever Pharma
- France · Atosiban Altan, Atosiban Altan Pharmaceuticals, S.A.
- United Kingdom (Northern Ireland) · Atosiban Ibigen
- Greece · Atosiban Ever Pharma
- Croatia · Atosiban Ever Pharma, Atosiban Makpharm
- Iceland · Atosiban Sun, Tractocile
- Italy · Atosiban Ever Pharma, Atosiban Ibisqus
- Liechtenstein · Tractocile
- Luxembourg · Atosiban Ever Pharma
- Latvia · Atosiban Pharmidea
- Netherlands · Atosiban Accord, Atosiban Ever Pharma
- Norway · Atosiban Ever Pharma, Atosiban Sun
- Poland · Atosiban Ever Pharma
- Portugal · Atosiban Ever Pharma, Atosibano Altan
- Slovenia · Atoziban Ever Pharma
- Slovakia · Atosiban Ardez
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e86fc18e-239d-48fa-9035-0cc11ea06d1f GET /v1/drugs/e86fc18e-239d-48fa-9035-0cc11ea06d1f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"SmPC"
],
"se_npl_id": "20150808000086",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20150808000086",
"product_doc_link": "https://docetp.mpa.se/LMF/Atosiban%20EVER%20Pharma%2075%20mg%20per%2010%20ml%20Concentrate%20for%20solution%20for%20infusion%20SmPC_09001bee807a3b3f.pdf"
}See everything about atosiban.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.